Lexi Ding

957 total citations
25 papers, 748 citations indexed

About

Lexi Ding is a scholar working on Molecular Biology, Ophthalmology and Cancer Research. According to data from OpenAlex, Lexi Ding has authored 25 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Ophthalmology and 4 papers in Cancer Research. Recurrent topics in Lexi Ding's work include Retinal Diseases and Treatments (7 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lexi Ding is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lexi Ding collaborates with scholars based in China, United States and Australia. Lexi Ding's co-authors include Jian‐xing Ma, Rui Cheng, Yusuke Takahashi, Yang Hu, Xuemin He, Ying Chen, Siqi Xiong, Xiaobo Xia, Kyungwon Lee and Elizabeth Moran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Diabetes.

In The Last Decade

Lexi Ding

24 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lexi Ding China 15 422 247 115 82 77 25 748
Takhellambam S. Devi United States 11 561 1.3× 243 1.0× 68 0.6× 108 1.3× 154 2.0× 13 863
Elizabeth Moran United States 9 299 0.7× 212 0.9× 106 0.9× 51 0.6× 30 0.4× 11 562
Kanako Izumi‐Nagai Japan 14 405 1.0× 558 2.3× 204 1.8× 50 0.6× 55 0.7× 15 994
Youde Jiang United States 20 488 1.2× 466 1.9× 107 0.9× 94 1.1× 194 2.5× 59 1.0k
Veronica Asnaghi United States 8 364 0.9× 407 1.6× 129 1.1× 88 1.1× 269 3.5× 14 938
Tahira Lemtalsi United States 17 391 0.9× 400 1.6× 127 1.1× 194 2.4× 122 1.6× 33 1.0k
Delu Song United States 22 397 0.9× 387 1.6× 124 1.1× 59 0.7× 32 0.4× 42 987
Mira M. Sachdeva United States 14 768 1.8× 295 1.2× 117 1.0× 88 1.1× 46 0.6× 24 1.3k
Elena Berrone Italy 11 169 0.4× 136 0.6× 56 0.5× 73 0.9× 104 1.4× 16 558
Tao He China 16 350 0.8× 146 0.6× 62 0.5× 118 1.4× 21 0.3× 43 680

Countries citing papers authored by Lexi Ding

Since Specialization
Citations

This map shows the geographic impact of Lexi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lexi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lexi Ding more than expected).

Fields of papers citing papers by Lexi Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lexi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lexi Ding. The network helps show where Lexi Ding may publish in the future.

Co-authorship network of co-authors of Lexi Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Lexi Ding. A scholar is included among the top collaborators of Lexi Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lexi Ding. Lexi Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Jingzhi, Jing Wang, Zhaolin Gao, Lexi Ding, & Xiaobo Xia. (2025). Scutellarin Protects Retinal Ganglion Cells in Glaucoma by Targeting the Hsp90aa1-MAPK Pathway to Inhibit Apoptosis. Investigative Ophthalmology & Visual Science. 66(14). 44–44.
2.
Wang, Chao, Zhaohua Xia, Xuezhi Zhou, et al.. (2022). The neuroprotective effect of melatonin in glutamate excitotoxicity of R28 cells and mouse retinal ganglion cells. Frontiers in Endocrinology. 13. 986131–986131. 21 indexed citations
3.
Yao, Fei, Xinyi Jiang, Zixuan Peng, et al.. (2022). Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice. Frontiers in Endocrinology. 13. 861452–861452. 5 indexed citations
4.
Wang, Nan, Lexi Ding, Die Liu, et al.. (2022). Molecular investigation of candidate genes for pyroptosis-induced inflammation in diabetic retinopathy. Frontiers in Endocrinology. 13. 918605–918605. 33 indexed citations
5.
Ding, Lexi, Jing Zhang, Sisi Yang, et al.. (2022). Heat Shock Proteins 70 Regulate Cell Motility and Invadopodia-Associated Proteins Expression in Oral Squamous Cell Carcinoma. Frontiers in Endocrinology. 13. 890218–890218. 2 indexed citations
6.
Li, Haibo, et al.. (2022). Nuclear factor erythroid 2-related factor 2 agonist protects retinal ganglion cells in glutamate excitotoxicity retinas. Biomedicine & Pharmacotherapy. 153. 113378–113378. 8 indexed citations
7.
Wang, Nan, et al.. (2022). Identification and Validation of Autophagy-Related Genes in Diabetic Retinopathy. Frontiers in Endocrinology. 13. 867600–867600. 38 indexed citations
8.
Yao, Fei, Xuan Zhang, Xueyan Yao, et al.. (2021). Peroxisome Proliferator-Activated Receptor α Activation Protects Retinal Ganglion Cells in Ischemia-Reperfusion Retinas. Frontiers in Medicine. 8. 788663–788663. 8 indexed citations
9.
Yan, Hong, et al.. (2021). The Anti-apoptotic Role of 3′-Untranslational Region in Response to Angiotensin II via Mcl1 Expression. Frontiers in Cell and Developmental Biology. 8. 593955–593955. 2 indexed citations
10.
Zhu, Ying, et al.. (2021). DNMT1-mediated PPARα methylation aggravates damage of retinal tissues in diabetic retinopathy mice. Biological Research. 54(1). 25–25. 24 indexed citations
11.
Xu, Yan, et al.. (2020). Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway. Biomedicine & Pharmacotherapy. 125. 109920–109920. 18 indexed citations
12.
Ding, Lexi, Shan Lü, Yu Zhou, et al.. (2020). The 3′ Untranslated Region Protects the Heart from Angiotensin II-Induced Cardiac Dysfunction via AGGF1 Expression. Molecular Therapy. 28(4). 1119–1132. 23 indexed citations
13.
Peng, Jing-Jie, et al.. (2019). Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target. European Journal of Pharmacology. 853. 381–387. 50 indexed citations
14.
Pearsall, Elizabeth, Rui Cheng, Satoshi Matsuzaki, et al.. (2019). Neuroprotective effects of PPARα in retinopathy of type 1 diabetes. PLoS ONE. 14(2). e0208399–e0208399. 35 indexed citations
15.
Xu, Hairong, et al.. (2018). Pulsatility Index as a Novel Parameter for Perfusion in Mouse Model of Hindlimb Ischemia. Cellular Physiology and Biochemistry. 48(5). 2114–2122. 3 indexed citations
16.
Xu, Hairong, Zejun Ma, Shan Lü, et al.. (2017). Renal Resistive Index as a Novel Indicator for Renal Complications in High-Fat Diet-Fed Mice. Kidney & Blood Pressure Research. 42(6). 1128–1140. 12 indexed citations
17.
Cheng, Rui, Lexi Ding, Xuemin He, Yusuke Takahashi, & Jian‐xing Ma. (2016). Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis. Diabetes. 65(12). 3730–3743. 61 indexed citations
18.
Ding, Lexi, Rui Cheng, Yang Hu, et al.. (2014). Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina. American Journal Of Pathology. 184(10). 2709–2720. 74 indexed citations
19.
Moran, Elizabeth, Lexi Ding, Zhongxiao Wang, et al.. (2014). Protective and Antioxidant Effects of PPARα in the Ischemic Retina. Investigative Ophthalmology & Visual Science. 55(7). 4568–4568. 63 indexed citations
20.
Hu, Yang, Ying Chen, Lexi Ding, et al.. (2013). THE PATHOGENIC ROLE OF DOWN-REGULATION OF PPAR-ΑLPHA EXPRESSION IN DIABETIC RETINOPATHY. Investigative Ophthalmology & Visual Science. 54(15). 1152–1152. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026